Vivoryon Therapeutics N.V. (AMS: VVY)
Netherlands
· Delayed Price · Currency is EUR
2.185
+0.010 (0.46%)
Jan 6, 2025, 9:13 AM CET
Vivoryon Therapeutics Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jan '25 Jan 3, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 57 | 212 | 249 | 380 | 180 | 109 | |
| Market Cap Growth | -84.91% | -14.71% | -34.60% | 111.35% | 65.63% | 417.15% | |
| Enterprise Value | 41 | 174 | 225 | 361 | 146 | 101 | |
| Last Close Price | 2.17 | 8.14 | 10.32 | 19.00 | 9.01 | 5.44 | |
| PS Ratio | -13.32 | -58.61 | - | 35.34 | - | - | |
| PB Ratio | 4.06 | 8.07 | 9.39 | 22.97 | 6.86 | 2.55 | |
| P/TBV Ratio | 3.69 | 8.37 | 9.56 | 23.74 | 7.02 | 2.55 | |
| EV/Sales Ratio | - | - | - | 33.52 | - | - | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | |
| Asset Turnover | - | - | - | 0.40 | - | - | |
| Quick Ratio | 9.12 | 9.30 | 9.35 | 3.57 | 19.95 | 45.30 | |
| Current Ratio | 9.37 | 9.37 | 9.40 | 4.00 | 21.73 | 48.79 | |
| Return on Equity (ROE) | -112.35% | -107.38% | -130.77% | -59.17% | -47.93% | -35.64% | |
| Return on Assets (ROA) | -62.86% | -56.74% | -65.10% | -29.48% | -26.47% | -19.52% | |
| Return on Capital (ROIC) | -70.48% | -66.65% | -83.81% | -36.93% | -28.75% | -21.99% | |
| Earnings Yield | -56.68% | -13.36% | -11.32% | -3.33% | -9.17% | -7.20% | |
| FCF Yield | -25.69% | -10.16% | -8.77% | -2.96% | -7.82% | -10.73% | |
| Buyback Yield / Dilution | -3.35% | -14.64% | -10.10% | -0.12% | -59.17% | -52.90% | |
| Total Shareholder Return | -3.35% | -14.64% | -10.10% | -0.12% | -59.17% | -52.90% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.